These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25886818)

  • 21. Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpura.
    Zhang Y; Kolesar JM
    Clin Ther; 2011 Nov; 33(11):1560-76. PubMed ID: 22054810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag.
    Erickson-Miller CL; Kirchner J; Aivado M; May R; Payne P; Chadderton A
    Leuk Res; 2010 Sep; 34(9):1224-31. PubMed ID: 20202683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
    Tanaka T; Inamoto Y; Yamashita T; Fuji S; Okinaka K; Kurosawa S; Kim SW; Tanosaki R; Fukuda T
    Biol Blood Marrow Transplant; 2016 May; 22(5):919-24. PubMed ID: 26785333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
    McHutchison JG; Dusheiko G; Shiffman ML; Rodriguez-Torres M; Sigal S; Bourliere M; Berg T; Gordon SC; Campbell FM; Theodore D; Blackman N; Jenkins J; Afdhal NH;
    N Engl J Med; 2007 Nov; 357(22):2227-36. PubMed ID: 18046027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders.
    Pathak S; Roth M; Verma A; Steidl U
    Expert Opin Drug Metab Toxicol; 2013 Dec; 9(12):1667-75. PubMed ID: 24215532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.
    Modi Y; Shaaban H; Gauchan D; Maroules M
    J Oncol Pharm Pract; 2015 Feb; 21(1):74-5. PubMed ID: 25063763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag.
    Suzuki N; Hiraga J; Hariyama Y; Takagi Y; Ohashi H; Kishigami Y; Oguchi H; Kagami Y
    Int J Hematol; 2018 Jul; 108(1):109-111. PubMed ID: 29188582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eltrombopag: a novel oral thrombopoietin receptor agonist.
    Corman SL; Mohammad RA
    Ann Pharmacother; 2010 Jun; 44(6):1072-9. PubMed ID: 20460556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.
    Erickson-Miller CL; Pillarisetti K; Kirchner J; Figueroa DJ; Ottesen L; Martin AM; Liu Y; Kamel YM; Messam C
    BMC Cancer; 2012 Sep; 12():405. PubMed ID: 22967017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag.
    Kao YR; Chen J; Narayanagari SR; Todorova TI; Aivalioti MM; Ferreira M; Ramos PM; Pallaud C; Mantzaris I; Shastri A; Bussel JB; Verma A; Steidl U; Will B
    Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias.
    Wesson W; Ahmed N; Rashid A; Tabak C; Logan E; Marchena-Burgos J; Nelson M; Davis JA; McGann M; Shune L; Hoffmann M; Abdallah AO; Hashmi H
    Eur J Haematol; 2024 Apr; 112(4):538-546. PubMed ID: 38044594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morbilliform eruption related to eltrombopag: emerging data on the cutaneous toxicity of thrombopoietin receptor agonists.
    Kazemi T; Martin S; Worswick S
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T; Harada Y; Matsubara E; Suzuki T; Oyama T; Kasai M; Uchida T; Ogura M
    J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein and Small-Molecule Leucopoiesis and Thrombopoiesis Stimulators.
    Farsa O; Zubáč P
    Mini Rev Med Chem; 2021; 21(13):1638-1645. PubMed ID: 33390132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag.
    Fujimi A; Kamihara Y; Hashimoto A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Ono K; Iyama S; Kato J
    Int J Hematol; 2015 Oct; 102(4):471-6. PubMed ID: 25964100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eltrombopag for the treatment of immune thrombocytopenia.
    Cheng G
    Expert Rev Hematol; 2011 Jun; 4(3):261-9. PubMed ID: 21671710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia.
    Hayes S; Mudd PN; Ouellet D; Johnson BM; Williams D; Gibiansky E
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1507-20. PubMed ID: 23564375
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    D'Alò F; Zangrilli I; Cupelli E; Fianchi L; Criscuolo M; Falconi G; Fabiani E; Pagano L; Hohaus S; De Stefano V
    Platelets; 2021 Apr; 32(3):378-382. PubMed ID: 32268817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel and simple hollow-fiber assay for in vivo evaluation of nonpeptidyl thrombopoietin receptor agonists.
    Xie CY; Xu YP; Zhao HB; Lou LG
    Exp Hematol; 2012 May; 40(5):386-92. PubMed ID: 22269115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombopoietin-receptor agonists for primary immune thrombocytopenia.
    Imbach P; Crowther M
    N Engl J Med; 2011 Aug; 365(8):734-41. PubMed ID: 21864167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.